MyD88 protein destabilization mitigates NF-κB-dependent protection against macrophage apoptosis

Area of Science:

• Immunology
• Cellular Biology
• Molecular Biology

Background:

• Signaling pathways are crucial for innate immunity and cell homeostasis.
• MyD88 is a key adaptor protein in innate immune signaling.
• Dysregulation of these pathways can lead to disease.

Purpose of the Study:

• To investigate the role of a specific MyD88 mutation (D162E) in inflammasome regulation and cellular homeostasis.
• To understand the impact of this mutation on immune cell function and apoptosis.
• To explore potential therapeutic strategies for MyD88-related conditions.

Main Methods:

• Introducing a caspase-1 recognition site mutation in MyD88 (MyD88^D162E) in mice.
• Inducing colitis using DSS in mutant and wild-type mice.
• Analyzing cytokine expression, oxidative stress, mitochondrial function, and apoptosis in bone marrow-derived macrophages (BMDMs).
• Assessing the effect of lipopolysaccharide (LPS) and ibrutinib treatment on cellular phenotypes.

Main Results:

• The MyD88^D162E mutation abolished inflammasome-dependent negative regulation.
• Mutant mice showed reduced colon inflammation but no change in cytokine expression in BMDMs.
• MyD88^D162E BMDMs exhibited increased oxidative stress, mitochondrial dysfunction, and apoptosis susceptibility.
• NF-κB activation by LPS mitigated the pro-apoptotic phenotype.

Conclusions:

• MyD88^wt signaling is vital for NF-κB activation and protecting macrophages from apoptosis.
• The MyD88^D162E mutation impairs cellular homeostasis by increasing apoptosis.
• Modulating MyD88 protein levels, not just signaling, may offer a therapeutic approach for MyD88-driven lymphomas.